These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 9663609)
1. Human neuroblastoma cells produce extracellular matrix-degrading enzymes, induce endothelial cell proliferation and are angiogenic in vivo. Ribatti D; Alessandri G; Vacca A; Iurlaro M; Ponzoni M Int J Cancer; 1998 Jul; 77(3):449-54. PubMed ID: 9663609 [TBL] [Abstract][Full Text] [Related]
2. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Vacca A; Ribatti D; Iurlaro M; Albini A; Minischetti M; Bussolino F; Pellegrino A; Ria R; Rusnati M; Presta M; Vincenti V; Persico MG; Dammacco F Int J Clin Lab Res; 1998; 28(1):55-68. PubMed ID: 9594364 [TBL] [Abstract][Full Text] [Related]
3. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. Seandel M; Noack-Kunnmann K; Zhu D; Aimes RT; Quigley JP Blood; 2001 Apr; 97(8):2323-32. PubMed ID: 11290594 [TBL] [Abstract][Full Text] [Related]
4. Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Ribatti D; Presta M; Vacca A; Ria R; Giuliani R; Dell'Era P; Nico B; Roncali L; Dammacco F Blood; 1999 Apr; 93(8):2627-36. PubMed ID: 10194442 [TBL] [Abstract][Full Text] [Related]
5. Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. Ribatti D; Nico B; Morbidelli L; Donnini S; Ziche M; Vacca A; Roncali L; Presta M J Vasc Res; 2001; 38(4):389-97. PubMed ID: 11455210 [TBL] [Abstract][Full Text] [Related]
6. In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression. Ribatti D; Raffaghello L; Pastorino F; Nico B; Brignole C; Vacca A; Ponzoni M Int J Cancer; 2002 Dec; 102(4):351-4. PubMed ID: 12402304 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of neuroblastoma-induced angiogenesis by fenretinide. Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408 [TBL] [Abstract][Full Text] [Related]
9. Anti-angiogenic activity of the purine analog 6-thioguanine. Presta M; Belleri M; Vacca A; Ribatti D Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690 [TBL] [Abstract][Full Text] [Related]
10. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Isaji M; Miyata H; Ajisawa Y; Takehana Y; Yoshimura N Br J Pharmacol; 1997 Nov; 122(6):1061-6. PubMed ID: 9401770 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Lamoreaux WJ; Fitzgerald ME; Reiner A; Hasty KA; Charles ST Microvasc Res; 1998 Jan; 55(1):29-42. PubMed ID: 9473407 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Vacca A; Ribatti D; Presta M; Minischetti M; Iurlaro M; Ria R; Albini A; Bussolino F; Dammacco F Blood; 1999 May; 93(9):3064-73. PubMed ID: 10216103 [TBL] [Abstract][Full Text] [Related]
14. Characterization of human chorionic gonadotropin as a novel angiogenic factor. Zygmunt M; Herr F; Keller-Schoenwetter S; Kunzi-Rapp K; Münstedt K; Rao CV; Lang U; Preissner KT J Clin Endocrinol Metab; 2002 Nov; 87(11):5290-6. PubMed ID: 12414904 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Wang H; Keiser JA Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730 [TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation. Zucker S; Mirza H; Conner CE; Lorenz AF; Drews MH; Bahou WF; Jesty J Int J Cancer; 1998 Mar; 75(5):780-6. PubMed ID: 9495249 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792 [TBL] [Abstract][Full Text] [Related]
18. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes. Bråkenhielm E; Cao R; Cao Y FASEB J; 2001 Aug; 15(10):1798-800. PubMed ID: 11481234 [No Abstract] [Full Text] [Related]
19. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Wilting J; Christ B; Bokeloh M; Weich HA Cell Tissue Res; 1993 Oct; 274(1):163-72. PubMed ID: 7694800 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiogenesis by humulone, a bitter acid from beer hop. Shimamura M; Hazato T; Ashino H; Yamamoto Y; Iwasaki E; Tobe H; Yamamoto K; Yamamoto S Biochem Biophys Res Commun; 2001 Nov; 289(1):220-4. PubMed ID: 11708802 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]